Welcome to our dedicated page for Intelligent Bio Solutions news (Ticker: INBS), a resource for investors and traders seeking the latest updates and insights on Intelligent Bio Solutions stock.
Intelligent Bio Solutions Inc (INBS) delivers innovative diagnostic solutions through its biosensor platform and fingerprint-based drug screening systems. This news hub provides investors and healthcare professionals with timely updates on the company’s advancements in non-invasive testing technologies.
Access comprehensive coverage of earnings reports, regulatory milestones, and product development progress. Stay informed about strategic partnerships and clinical validation studies that shape INBS’s position in life sciences. Our curated news collection simplifies tracking critical developments in portable drug screening and chronic disease monitoring solutions.
Discover updates on the Intelligent Fingerprinting Products segment’s commercial deployments and the evolving Biosensor Platform Technology applications. Bookmark this page for efficient monitoring of INBS’s contributions to modern healthcare diagnostics and workplace safety innovations.
Rhea-AI Summary
Intelligent Bio Solutions Inc. (Nasdaq: INBS) announced that DGP Plc has selected the Intelligent Fingerprinting Drug Screening System to enable in-house drug testing for its 450 employees and contractors, simplifying and speeding up the process. The portable system allows for faster, more convenient, and flexible workplace drug testing, resulting in overall cost savings and improved productivity due to minimal disruption.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.05%
Tags
-
Rhea-AI Summary
Intelligent Bio Solutions Inc. (INBS) announced that Robinson Brothers, a UK chemical manufacturer, is now using its portable Intelligent Fingerprinting Drug Screening System for in-house drug testing. The system offers portability, flexibility, and ease-of-use, enabling random testing and for cause tests across the business. This move aims to improve efficiency and productivity for Robinson Brothers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.41%
Tags
-
Rhea-AI Summary
Intelligent Bio Solutions Inc. (INBS) has received NATA accreditation for its Intelligent Fingerprinting Drug Screening Solution, aligning with international standards and providing broad opportunities for the company. The accreditation supports the business operations and market presence, positioning INBS as a trusted partner for organizations with stringent drug and alcohol testing policies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.22%
Tags
Rhea-AI Summary
Intelligent Bio Solutions Inc. (Nasdaq: INBS) announced that leading pan-European ferry and logistics company, P&O Ferries, is now using the revolutionary portable Intelligent Fingerprinting Drug Screening System to support its drug and alcohol testing policy. The system is expected to reduce P&O Ferries’ overall drug testing costs by 90%. P&O Ferries will deploy the system at its three UK ferry port sites at Larne in Northern Ireland, as well as Hull and Dover in England.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
-
Rhea-AI Summary
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced that Titan Cranes and Rigging Pty Ltd. has adopted the Company's Intelligent Fingerprinting Drug Screening System. Titan is Australasia’s leading specialist material handling company, contributing to Australia’s construction industry, which generates over $360 billion in annual revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
64.06%
Tags
-
News
Rhea-AI Summary
Intelligent Bio Solutions Inc. (Nasdaq: INBS) will present at the Emerging Growth Conference on December 7, 2023. The Company will showcase its proprietary Intelligent Fingerprinting Drug Screening System. Harry Simeonidis, President and CEO, will present at 2:20 p.m. Eastern Time. An archived webcast will be available on emerginggrowth.com and the Emerging Growth YouTube Channel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.91%
Tags
Rhea-AI Summary
Intelligent Bio Solutions Inc. (INBS) announced that State Road Constructions selected its Intelligent Fingerprinting Drug Screening System for workplace drug screening. The system offers non-invasive, rapid drug testing using fingertip sweat, aligning with State Road's dedication to operational efficiency. It detects major drugs of abuse within a 14-16 hour window, maintaining employee privacy and workplace safety. The system's portability makes it suitable for safety-critical industries like construction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.86%
Tags
-
Rhea-AI Summary
INBS (Nasdaq: INBS) reported a 191% year-over-year increase in combined revenue and government support income for the first fiscal quarter ended September 30, 2023, reaching $0.91 million. The company also achieved an 88% sequential increase due to strong organic growth and expansion plans. INBS expanded into the South American market, advanced plans for the U.S. market, and completed a critical development milestone for new assays for its Intelligent Fingerprinting Drug Screening System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
92.51%
Tags
-
Rhea-AI Summary
Intelligent Bio Solutions Inc. expands into the New Zealand market with its Intelligent Fingerprinting Drug Screening System, aiming to meet the screening needs of businesses and support health and safety initiatives. The system offers a non-invasive alternative to traditional drug testing methods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.13%
Tags
Rhea-AI Summary
Intelligent Bio Solutions announces adoption of its Intelligent Fingerprinting Drug Screening System by VKVP Haulage and successful completion of 25,000 tests by Auctus Management Group
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.14%
Tags
Intelligent Bio Solutions Inc
Nasdaq:INBS
INBS Rankings
INBS Stock Data
8.07M
6.69M
1.89%
1.27%
6.7%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
NEW YORK